Nexilin-like Protein (NEXN) Gene Mutation Analysis
The NEXN gene is located in the short (p) arm of chromosome 1 at position 31.1 and encode a cardiac Z-disc protein, nexilin. This protein has an essential role in the maintenance of the Z-disc, sarcomere integrity and it protects cardiac Z-discs from forces generated within the sarcomere. Mutation in NEXN gene destabilizes cardiac Z-disc and can cause both dilated cardiomyopathy and hypertrophic cardiomyopathy. Various pathogenic variants including missense, splicing, small /gross deletions have been identified in NEXN.
DCM is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Dilated cardiomyopathy (DCM) is most commonly inherited in an autosomal dominant or X-linked manner. DCM is the most common cause of congestive heart failure in young patients, although, conduction impairment, syncope and sudden death may also occur. It affects approximately 1 per 2,500 in the adult population. Many patients with dilated cardiomyopathy have no or only minor symptoms and live a normal life. Other individuals may develop symptoms such as fatigue, weight loss, fainting, palpitation, chest pain and sudden death. Inherited DCM can be categorized as acquired, syndromic, or non-syndromic depending on the causative mutation. Mutations in NEXN account for < 1% of inherited DCM.
Familial hypertrophic cardiomyopathy (HCM) is an inherited heart disorder characterized by unexplained left ventricular (LV) hypertrophy (thickening) associated with non-dilated ventricular chambers. HCM is diagnosed by identifying a left ventricular maximum wall thickness ≥15 mm in adults, ≥13 mm in a relative inherited from the family's pathogenic sarcomere variant, or a z-score >3 in children. Characteristic pathological features include myocardial fiber hypertrophy, disorganized myocardial cells, interstitial fibrosis and thickened intra-myocardial coronary vessels. The majority of HCM patients are asymptomatic. About 25% develop symptom such as dyspnea, syncope, collapse, palpitations, and chest pain. The disorder has inter- and intrafamilial variability ranging from benign cases to malignant forms with a high risk of cardiac failure and sudden cardiac death. HCM is typically inherited in an autosomal dominant manner. Familial hypertrophic cardiomyopathy affects an estimated 1 in 500 people worldwide. Mutations in NEXN account for < 1% of inherited HCM.
- As an aid in diagnosis of familial hypertrophic cardiomyopathy and dilated cardiomyopathy
- Carrier screening for relatives and those with the family history
- Prenatal carrier screening for those with the family history
Negative for mutations analyzed (No pathogenic variant or mutation detected)
Whole blood (EDTA).
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: Unacceptable
- Mol Cell Probes. 2015 Oct;29(5):308-14. [PMID: 25979592]
- Heart Fail Rev. 2019;24: 439-459. [PMID: 30852773]
- J Cell Biol. 1998 Nov 30;143(5):1227-38. [PMID: 9832551]
- J Hum Genet. 2016;61: 41-50. [PMID: 26178429]
- Cell Mol Life Sci. 2015;72: 3185-3200. [PMID: 25809162]
- J Card Fail. 2012; 18: 296-303. [PMID: 22464770]
- Am J Hum Genet. 2010;87: 687-93. [PMID: 20970104]
- J Hum Genet. 2003;48: 55-64. [PMID: 12601548]
- J Cell Biol. 1998;143: 1227-1238. [PMID: 9832551]